close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CinCor Pharma, Inc. - Common Stock (NQ:CINC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CinCor Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Opening Day: Credo Rises In First Trading Day Despite Tough IPO Market
Shares of Credo Technology rose more than 12% in their first trading day despite a tough IPO market. This was the first big technology offering of the year after Justworks postponed its deal that had... 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Provention Bio (NASDAQ:PRVB) stoc... 
Via Benzinga
CinCor Pharma's Ex-Dividend Date Is Sunday, Here's What You Need To Know
Sunday marks the last chance for investors to receive the next dividend payout from CinCor Pharma. What's Happening (NASDAQ: 
Via Benzinga
3 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... 
Via Benzinga
10 Best Stocks to Buy on the Nasdaq Right Now
The tech-centric index is hurting significantly more than its peers, presenting opportunities for bold speculators. 
Via InvestorPlace
53 Biggest Movers From Friday
Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle... 
Via Benzinga
45 Stocks Moving In Monday's Mid-Day Session
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88. Zynga Inc. (NASDAQ: ZNGA) gained 45.7% to $8.74 after the company announced it will be acquired... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday. Zynga Inc. (NASDAQ: ZNGA) rose 40.7% to settle at $8.44 after the company... 
Via Benzinga
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today